10x Genomics Inc (NAS:TXG)
$ 24.48 -0.35 (-1.41%) Market Cap: 2.93 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.07 GF Score: 75/100

10X Genomics Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 04:30PM GMT
Release Date Price: $84.61 (+1.06%)
Tejas Rajeev Savant
JP Morgan Chase & Co, Research Division - Analyst

Good morning, everyone. My name is Tejas Savant, and I work on the life sciences team at JPMorgan. It's my pleasure this morning to introduce Serge Saxonov, Founder and CEO of 10x Genomics. At the end of Serge's presentation, there will be a breakout with the management team in the Olympic room, that's outside to your left.

And with that, I'd like to hand it over to Serge.

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Thank you. So please note that a webcast of this presentation and our 10-Q are available on our website. During this presentation, we may make forward-looking statements to which you should not place undue reliance. We disclaim any intention or obligation to update or revise any of these statements.

Material risks and uncertainties may cause actual events to differ from those anticipated. Additional information regarding these risks, uncertainties and forward-looking statements can be found in our filings with the SEC.

Last

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot